What Viromii does

Viromii is a Valencia-headquartered consulting firm, founded in 2017 and operating as a Spanish Sociedad Limitada (VIROMII INNOVATION.S.L.), that specializes in research valorization and technology transfer for the R&D ecosystem. Its core offering is a portfolio of professional services — research valorization, technology transfer, regulatory roadmaps, training, business plans for spin-offs, market research, business development support, and investor matchmaking — delivered to universities, public research centers, technology-based spin-offs and startups, high-tech companies, and investors. The firm differentiates on a tailored, end-to-end engagement model (it accompanies clients throughout the project rather than delivering a report and disengaging) and on proprietary databases and methods used to identify commercialization pathways for research outputs.

The company has a small operating footprint of 1-10 employees and is founder-owned and bootstrapped, with no disclosed equity funding rounds, institutional investors, or M&A activity. Its customer base is concentrated in the Spanish public research sector, with named engagements including Universitat Politècnica de València (UPV), CSIC, INCLIVA, Hospital General Universitario de Valencia, and Instituto Maimónides de Investigación Biomédica de Córdoba, and includes international logos such as the University of Gothenburg. A landmark commercial outcome was the licensing of a patented dsRNA production method developed by IBMCP (UPV-CSIC) to a leading US biotechnology company in 2020-2021. The most recent strategic move is participation in the BIOVALSA consortium with AIMPLAS and partners (announced January 2026), funded by IVACE+i and ERDF, targeting sustainable bioplastics from agricultural waste.

Viromii's go-to-market is sales-led direct B2B consulting, supported by content marketing (company website, blog, email) and professional networking on LinkedIn. Pricing is quote-based and tailored to each engagement, with no publicly disclosed rates or standard pricing model. Geographic reach is described as international, with partners, clients, and team members distributed globally, though no formal offices outside Valencia are disclosed. Revenue figures are not publicly reported, and the firm does not appear to operate a software product, app, API, or AI/ML capability that would alter its classification as a traditional professional services intermediary.

Name

Viromii

Legal name

VIROMII INNOVATION.S.L.

Website

https://viromii.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Viromii is a Valencia, Spain-based consulting firm founded in 2017 that provides research valorization, technology transfer, and business development services to universities, research centers, spin-offs, startups, and investors.

Ownership category

akta.pro rank

Product category

Technology Transfer Consulting

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL)

Keywords

• Technology transfer consulting
• Research valorization services
• Innovation commercialization consulting
• Biotech business development
• Investor matchmaking services

Headquarters

HQ city

Castellar De N'hug

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Consulting Services Revenue: Professional consulting services for research valorization, technology transfer, regulatory roadmaps, training, business plans, market research, and business development support for R&D institutions and tech companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Viromii is a consulting firm that helps R&D institutions, universities, spin-offs, startups, and high-tech companies bring research innovations to market. It delivers tailored research valorization, technology transfer, regulatory roadmap, training, business plan, market research, and business development services, complemented by investor matchmaking, using proprietary databases and methods.

Product overview

Viromii is a consulting firm focused on innovation and technology transfer, supporting R&D institutions and tech-companies. The company offers a portfolio of professional services including Research Valorization, Technology Transfer, Regulatory Roadmaps, and Training for R&D institutions, as well as Business Plans for Spin-offs, Market Research and Evaluations, and Business Development Support for spin-offs and startups. The firm works with universities, research centres, high-tech companies and investors worldwide to help bring innovations to market.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Valorization Service helping R&D institutions transform research outcomes into commercially viable opportunities. Targeted at universities, research centres, and public R&D bodies.
• Technology Transfer Service facilitating the movement of innovations from research institutions to commercial applications, including licensing of technologies to companies.
• Regulatory Roadmaps Service guiding R&D institutions and tech companies through compliance and regulatory requirements for bringing innovations to market.
• Training Training programs for R&D institutions on innovation and technology transfer processes.
• Business Plans for Spin-offs Business plan development service for spin-offs and startups emerging from research institutions, supporting market entry and growth.
• Market Research and Evaluations Market research and evaluation services for spin-offs and startups to assess commercial potential and validate opportunities.
• Business Development Support Ongoing business development support provided throughout client projects, accompanying clients beyond a report deliverable.
• Investor Matchmaking Investor matchmaking service connecting startups and spin-offs with potential investors across biotech, cleantech, agrotech, and other high-impact sectors.

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• AIMPLAScoreStrategic or Co-development Partner · 8 January 2026AIMPLAS (Plastics Technology Centre) coordinates the BIOVALSA project for sustainable bioplastics from agricultural waste. Viromii participates as a partner in this R&D collaboration funded by IVACE+i and ERDF funds, contributing to research valorization and technology transfer activities.
• FoodUPVminorStrategic or Co-development PartnerFoodUPV is a partner in the BIOVALSA project consortium, contributing to the development of innovative processes for manufacturing sustainable bioplastics from agricultural waste.
• BiobanminorStrategic or Co-development PartnerBioban is a partner in the BIOVALSA project consortium focused on converting agricultural waste into sustainable bioplastics.
• Prime BiopolymersminorStrategic or Co-development PartnerPrime Biopolymers is a partner in the BIOVALSA project consortium working on bioplastic manufacturing from agricultural residues.
• Universitat Politècnica de València (UPV) - I2TcoreStrategic or Co-development PartnerViromii collaborated with the Research, Innovation and Transfer Promotion and Support Service (I2T) of UPV to drive technology transfer of dsRNA production method. I2T is UPV's technology transfer office.
• Instituto de Biología Molecular y Celular de Plantas (IBMCP)coreTechnology or IntegrationIBMCP (UPV-CSIC joint institute) developed the patented dsRNA production technology that Viromii helped commercialize, successfully licensing it to a US biotechnology company.
• Various Universities and Research InstitutionscoreStrategic or Co-development PartnerViromii works with universities, research centres, and prominent institutions from all over the world as clients and partners in technology transfer projects.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Mind the Bridge: Open-innovation and technology-transfer consultancy with offices in San Francisco and Europe; directly comparable for cross-border R&D commercialization mandates and corporate-startup bridge programs.
• Oxentia: Oxford University spin-out technology-transfer and innovation consultancy; highly comparable in service mix (valorization, licensing support, spin-out advisory) for research institutions worldwide.
• PNO Innovation: European innovation and R&D grants consultancy supporting consortia like Horizon Europe; directly comparable on R&D valorization, partnership building, and EU-funded project participation.
• Innoget: Global innovation marketplace and technology-transfer platform connecting research organizations with industry and investors; competitive overlap in open innovation, matchmaking, and tech-transfer services.
• Catalyze: European life-sciences and health innovation consultancy supporting commercialization of academic research; comparable in fund/grant acquisition and spin-out support across academic clients.
• FundingBox: European grants and innovation funding consultancy operating across EU member states; overlapping services in EU funding capture and R&D program support.

Regional players

• Biocat: Catalan biotech and health innovation ecosystem organization that runs valorization and acceleration programs; comparable for biotech-focused research-to-market activities, but region-specific (Catalonia).
• CDTI (Centro para el Desarrollo Tecnológico e Industrial): Spanish public R&D and innovation funding agency that funds and supports technology-transfer projects; direct overlap on Spanish R&D valorization mandates and EU-funding advisory.

Broad incumbents

• Eurecat: Large Catalan technology center providing applied R&D and innovation services; comparable for technology-transfer and research valorization work but at a much wider scope and scale.
• Asabys Partners: Barcelona-based healthcare and life-sciences venture capital firm that also supports spin-outs and academic commercialization; relevant adjacent player for biotech investor matchmaking.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/viromii

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viromii